Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study

被引:0
作者
Manabu Kato
Hitoshi Ishizuka
Takashi Taguchi
Kazuhito Shiosakai
Emi Kamiyama
Michio Sata
Takafumi Yoshida
机构
[1] Daiichi Sankyo Co.,Incorporated Medical Corporation Applied Bio
[2] Ltd.,Pharmatech Kurume Clinical Pharmacology Clinic
[3] Kurume University School of Medicine,undefined
来源
Advances in Therapy | 2018年 / 35卷
关键词
Diabetes; DS-8500a; Hepatic impairment; Pharmacokinetics; Renal impairment; Safety;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1239 / 1250
页数:11
相关论文
共 41 条
[1]  
Cerf ME(2013)Beta cell dysfunction and insulin resistance Front Endocrinol (Lausanne) 4 37-2047
[2]  
Chu ZL(2008)A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release Endocrinology 149 2038-2609
[3]  
Carroll C(2007)A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release Endocrinology 148 2601-41
[4]  
Alfonso J(2011)The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function Diabetes Obes Metab 13 34-3592
[5]  
Chu ZL(2016)G protein-coupled receptor 119 (GPR119) agonists for the treatment of diabetes: recent progress and prevailing challenges J Med Chem 59 3579-649
[6]  
Jones RM(2016)DS-8500a, a novel orally available GPR119 agonist improves glucose tolerance in type 2 diabetic rats Diabetes 65 Abstract 1124-P-75
[7]  
He H(2018)Safety and pharmacokinetics of DS-8500a, a novel GPR119 agonist, after multiple oral doses in healthy Japanese males Clin Drug Investig 60 646-1624
[8]  
Yoshida S(1973)Transection of the oesophagus for bleeding oesophageal varices Br J Surg 23 67-259
[9]  
Ohishi T(2016)The effects of CKD on cytochrome P450-mediated drug metabolism Adv Chronic Kidney Dis 39 1617-undefined
[10]  
Matsui T(1996)Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment Diabetologia 43 252-undefined